The bill, HB 648-FN, aims to improve health insurance coverage for individuals with diabetes by mandating that health insurance providers cover glucose monitoring devices and supplies, as well as medically necessary outpatient self-management training and educational services. Key provisions include a cap of $30 on copayments for each 30-day supply of covered insulin prescriptions, which will not be subject to any deductible. The bill also ensures that coverage for glucose monitoring devices, including continuous glucose monitoring systems (CGMS), is provided without deductibles and does not require prior authorization or referrals. Additionally, it amends RSA 420-B:8-k to require health maintenance organizations (HMOs) to cover necessary diabetes treatment equipment without regard to insulin usage or frequency of blood glucose testing.

The legislation includes several important insertions, such as definitions for glucose monitoring systems and specific coverage requirements, while deleting previous stipulations regarding coverage. It also establishes conditions for continued coverage, requiring recipients to participate in follow-up care with their healthcare practitioners at specified intervals. Overall, the bill seeks to enhance access to essential diabetes management tools and services, although it may lead to increased claims and potentially higher insurance premiums, with the exact fiscal impact remaining uncertain.

Statutes affected:
Introduced: 415:6-e, 415:18-f, 420-A:17-a, 420-B:8-k
HB648 text: 415:6-e, 415:18-f, 420-A:17-a, 420-B:8-k